Close
  Indian J Med Microbiol
 

Figure 2: Cumulative incidence of disease relapse among different hormone receptor groups according to the pathological complete response status. (a) Among hormone receptor+ (HR) and human epidermal growth factor receptor 2+ (HER2) (b) Among HR + and HER2− (c) Among HR − and HER2+ (d) Among triple negative breast cancer

Figure 2: Cumulative incidence of disease relapse among different hormone receptor groups according to the pathological complete response status. (a) Among hormone receptor+ (HR) and human epidermal growth factor receptor 2+ (HER2) (b) Among HR + and HER2− (c) Among HR − and HER2+ (d) Among triple negative breast cancer